Advertisement

Bracco Diagnostics Inc. Company Profile

00:20 EDT 20th May 2013 | BioPortfolio

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging develops, manufactures and markets diagnostic imaging agents and solutions that meet medical needs.


News Articles [ 414 Associated News Articles listed on BioPortfolio]

U.S. subsidiary of Bracco Imaging gets new CEO

Vittorio Puppo has been tapped to replace Carlo Medici as CEO of Bracco Diagnostics, the U.S. subsidiary of Bracco Imaging.  -More- 

FDA approves use of Bracco's MultiHance injection in MRA

The Bracco Diagnostics has gained FDA approval for the use of MultiHance (gadobenate dimeglumine) injection, 529mg/ml, in magnetic resonance angiography (MRA) to evaluate adults with known or suspecte...

Isovue (iopamidol injection) Pre-Filled Power Injector Syringes by Bracco Diagnostics Inc.: Recall - Presence of Particulates

Audience: Risk Manager, Cardiology [Posted 11/28/2012] ISSUE: Bracco Diagnostics Inc. (BDI) is voluntarily initiating a Class I recall of nine (9) lots of Isovue (iopamidol injection) Pre-Filled Powe...

Bracco Diagnostics, Emergent BioSolutions deal

FDA OKs wider use of Bracco's MR contrast agent

Bracco Diagnostics has received expanded FDA approval for use of its MultiHance contrast agent in magnetic resonance angiogra -More- 

FDA approves Bracco MultiHance injection for MRA use

Bracco Diagnostics has obtained the US Food and Drug Administration (FDA) clearance for use of its MultiHance (gadobenate dimeglumine) injection, 529 mg/mL, in magnetic resonance angiography (MRA), de...

FDA Drug Safety Communication: Planned return of CardioGen-82 to market with new Boxed Warning

[2-15-2012] The U.S. Food and Drug Administration (FDA) is notifying healthcare professionals; in particular, the medical imaging community, about the planned return of CardioGen-82 to the U.S. market...

FDA Drug Safety Communication: Update: Preliminary findings from ongoing investigations of CardioGen-82

[1-12-2012] The U.S. Food and Drug Administration (FDA) is updating healthcare professionals and the public about preliminary findings from ongoing investigations following the voluntary recall of Car...

Drugs and Medications [ 26 Associated Drugs and Medications listed on BioPortfolio]

Oxygen [A.M. Home Diagnostics Inc. dba Healthline]

Oxygen

Cystografin dilute diatrizoate meglumine injection usp 18% [Bracco Diagnostics Inc.]

CYSTOGRAFIN DILUTE Diatrizoate Meglumine Injection USP 18%

Cystografin diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

CYSTOGRAFIN Diatrizoate Meglumine Injection USP 30%

Multihance [Bracco Diagnostics Inc]

These highlights do not include all the information needed to use MultiHance safely and effectively. See full prescribing information for MultiHance. MultiHance (gadobenate dimeglumine) injection Init...

Reno-30 diatrizoate meglumine injection usp 30% [Bracco Diagnostics Inc.]

RENO-30 Diatrizoate Meglumine Injection USP 30%

PubMed Articles [ 183 Associated PubMed Articles listed on BioPortfolio]

The synthesis and application of polyamino polycarboxylic bifunctional chelating agents.

Bifunctional chelating agents (BFCAs) are molecules which contain two different moieties: a strong metal chelating unit and a reactive functional group. The latter is directed to react with amines, th...

Summary of technical principles of contrast sonography and future perspectives.

Ultrasound contrast agents have considerably expanded the range of ultrasound diagnostics. Up to date ultrasound machines with contrast-specific software allow the selective demonstration and quantifi...

Electron and nuclear spin dynamics in the thermal mixing model of dynamic nuclear polarization.

A novel mathematical treatment is proposed for computing the time evolution of dynamic nuclear polarization processes in the low temperature thermal mixing regime. Without assuming any a priori analyt...

Volatile agents for ICU sedation?

Microfluidic diagnostics for the developing world.

For more than a decade, it has been expected that microfluidic technology would revolutionize the healthcare industry with simple, inexpensive, effective, and ubiquitous miniature diagnostic devices....

Clinical Trials [ 43 Associated Clinical Trials listed on BioPortfolio]

Evaluation of the Performance of Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 Rapid Test

This study has been designed to evaluate the performance of the Chembio Diagnostics Systems, Inc. DPP® HIV 1/2 rapid test. The device is intended to qualitatively detect the presence of...

Diagnostics and Therapy of Disease-Related Quality of Life of Patients With Breast Cancer

Quality of Life-Diagnostics and -Therapy in Individual Patients with Breast Cancer. A randomized study including 200 patients, 5 clinics and 43 general practitioners as coordinating docto...

Implementation of Quality of Life Diagnostics and Therapy

Implementation and Evaluation of Implementation of Quality of Life Diagnostics and Therapy in Individual Patients with Breast Cancer. A prospective study including 170 patients, 5 clinics...

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

The Radata-Fuzeon cohort is an observational cohort study to gain a better understanding of Fuzeon (Enfuvirtide) in daily clinical practice. Patients planned to take this drug in a new ant...

BRADYCARE: Advanced Bradycardia Device Feature Utilization and Clinical Outcomes

Pacemaker technology is constantly evolving. In the past 10 years, numerous advancements have been made in pacemaker therapy, diagnostics and connectivity. These advancements include autom...

Companies [ 737 Associated Companies listed on BioPortfolio]

Bracco Diagnostics Inc.

Bracco Imaging S.p.A., part of the Bracco Group, is one of the world’s leading companies in the diagnostic imaging business. Headquartered in Milan, Italy, Bracco Imaging dev...

Bracco Imaging S.p.A.

Bracco Imaging S.p.A. is one of the World’s leading companies in the diagnostic imaging business. Bracco Imaging develops, manufactures and markets diagnostic imaging agents...

Bracco Diagnostics Inc

Bracco, founded in 1927 by the family who gave it its name and which has been at its helm for three generations and still runs it today, is an integrated Healthcare Group, world leader in global solut...

Sekisui Diagnostics

A Sekisui Chemical company since 2011, Sekisui Diagnostics is a leading supplier of high quality products to diagnostic manufacturers, clinical laboratories and physician offices...

Innotrac Diagnostics Oy

Founded 1995Located in Turku, FinlandInnotrac Diagnostics provides health care professionals with a comprehensive immunoassay platform and test portfolio for rapid and high quality results in cardiac...

More Information about "Bracco Diagnostics Inc." on BioPortfolio

We have published hundreds of Bracco Diagnostics Inc. news stories on BioPortfolio along with dozens of Bracco Diagnostics Inc. Clinical Trials and PubMed Articles about Bracco Diagnostics Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Bracco Diagnostics Inc. Companies in our database. You can also find out about relevant Bracco Diagnostics Inc. Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement